Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 27, 2025

Bitcoin hits a new all-time high, with a target of $150,000, and Trump signs an executive order to include it in the national strategic reserve
Dublin, California, May 27, 2025 (GLOBE NEWSWIRE) -- The price of Bitcoin surpassed $111,000 on May 22, setting a new all-time high. The rally was mainly driven by a large inflow of funds into cryptocurrency exchange-traded funds (ETFs), showing strong …

Zefiro Subsidiary Successfully Arranges Secured Loan to Resolve its Recently Announced Promissory Note Matter
For the principal purpose of repaying a promissory note payable to Stephen Plants for Zefiro’s acquisition of Plants …

Aptose Announces Results from Annual and Special Meeting of Shareholders
SAN DIEGO and TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Introducing Martini Market: A Decentralized Prediction Market on the XRP Ledger
DUBAI, United Arab Emirates, May 27, 2025 (GLOBE NEWSWIRE) -- As the XRP Ledger (XRPL) continues its evolution into a robust platform for decentralized finance (DeFi), the emergence of innovative applications is reshaping the landscape. Among these, …

Treatment.com AI Grants Stock Options and RSUs
VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) announces that it has granted an additional 633,589 restricted share units (“RSUs”) and 330,132 stock options (“ …

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …

GDS Announces Proposed Offering of US$450 Million Convertible Senior Notes
SHANGHAI, China, May 27, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the commencement of a …

GDS Announces Proposed Offering of American Depositary Shares in connection with the Delta Placement of Borrowed ADSs
SHANGHAI, China, May 27, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the commencement of a …

GDS Announces Launch of Proposed Public Offering of ADSs
SHANGHAI, China, May 27, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the commencement of a …

INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …

Inventronics Announces 2025 Q1 Financial Results
CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (“Corporation”) (IVX: TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and the …

QCI’s CTO Andrew Cardno to Speak at C2G Conference on the Power of Analytic Theories in Bingo and Slots
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is proud to announce that Andrew Cardno, Chief Technology Officer of QCI, will be a featured speaker at the upcoming Class 2 Gathering (C2G) Conference, taking place June 2–4, 2025 …

ControlUp Named a Leader in the 2025 Gartner® Magic Quadrant™ for Digital Employee Experience Management Tools for the Second Consecutive Year
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- ControlUp, a global leader in Digital Employee Experience (DEX) management tools, today announced it has been named a Leader in the 2025 Gartner® Magic Quadrant™ for Digital Employee Experience Management …

iQor CXBPO™ Expands in Santa Rosa With a New State-of-the-Art CX Facility
FT. LAUDERDALE, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- iQor CXBPO™, an award-winning customer experience business process outsourcing (BPO) solutions provider, today announced the expansion of its operations in Santa Rosa, Philippines. The new facility …

TransAlta Renews Normal Course Issuer Bid
CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) announced today that the Toronto Stock Exchange (“TSX”) has accepted the notice filed by the Company to implement a normal course …

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging …

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City …

Zscaler to Accelerate Innovation in AI-Powered Security Operations with Acquisition of Red Canary
SAN JOSE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced it has signed a definitive agreement to acquire Red Canary, a recognized leader in Managed Detection and Response (MDR). With over …